Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dementia due to Alzheimer's disease.

Journal of Alzheimer's disease : JAD - 1 Jan 2014

de Oliveira Fabricio Ferreira, Bertolucci Paulo Henrique Ferreira, Chen Elizabeth Suchi, Smith Marilia Cardoso

Abstract excerpt

Controversy over benefits of angiotensin-converting enzyme inhibitors (ACEIs) for treatment of dementia due to Alzheimer's disease (AD) led to this alternative investigational approach by the employment of pharmacogenetic methods, correlating the cognitive change of patients with late-onset AD with the presence of common ACE gene promoter polymorphisms, and stratifying the sample in groups of patients who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Angiotensin-Converting Enzyme Inhibitors

Share to Cognition Disorders

Share to Mental Status Schedule

Share to Neuropsychological Tests

Share to Peptidyl-Dipeptidase A

Share to Pharmacogenetics

Source

Identifiers

PMID: 24577465
DOI: 10.3233/JAD-132189

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dementia due to Alzheimer's disease.PMID 24577465Read ↗

Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia.Semantic proximity Read ↗

Pharmacogenetics of angiotensin modulators according to APOE-ϵ4 alleles and the ACE insertion/deletion polymorphism in Alzheimer's disease.Semantic proximity Read ↗

Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease.Semantic proximity Read ↗

Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.Semantic proximity Read ↗

Class-Specific Antihypertensives and Alzheimer's Disease: Genotype- and Hypertension-Stratified Analysis.Semantic proximity Read ↗

An age effect on the association of common variants of ACE with Alzheimer's disease.Semantic proximity Read ↗

A pharmacogenomic approach to Alzheimer's disease.Semantic proximity Read ↗

The ACE Gene Is Associated with Late-Life Major Depression and Age at Dementia Onset in a Population-Based Cohort.Semantic proximity Read ↗

Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson's disease.Semantic proximity Read ↗

The Impact of Angiotensin-Converting Enzyme Gene on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease.Semantic proximity Read ↗

Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data.Semantic proximity Read ↗

Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: A pilot study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.